Pick Today's Price Range Low-High... Just for Fun, page-228

I think the company should poach her. She will be another great hire after Dr. Rose - it makes a lot of sense to me. Wonder what she’s doing Downunder besides attending that conference.

All that said, I don’t run the company, so it’s just idle talk. I must say, though, that it is good to see a biotech run by ex medical practitioners besides bioscientists. The medical doctors have pressed their flesh with a lot of real patients and that makes all the difference IMO. Besides, it is good to have more American accent in top management - it think it appeals to a certain sentiment in that country where the FDA is.